Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Single-Blind, Positive-Controlled Clinical Trial of Absorbable Multilayer Fibrillar Regenerated Oxidized Cellulose for Surgical Hemostasis

NCT07764055 is registered in ClinicalTrials.gov with Medprin Regenerative Medical Technologies Co., Ltd. as lead sponsor.

NCT NCT07764055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07764055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Single-Blind, Positive-Controlled Clinical Trial of Absorbable Multilayer Fibrillar Regenerated Oxidized Cellulose for Surgical Hemostasis
Lead sponsor
Medprin Regenerative Medical Technologies Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
November 9, 2022
Completion date
March 5, 2024
Enrollment
288 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, oxidized regenerated cellulose, surgical bleeding